Posted on

Customized microdosing kits

Red Light Holland Files International Patent Application for ‘Find Your Dose’ Customization of Microdosing Kits Based on Biometric and Movement Data

Red Light Holland (TRIP) recently filed an international patent application for its “Find Your Dose” custom microdosing kits.

The kits help individuals get the most out of microdosing by providing personalized protocols based on biometric and movement data. 

This week, the company successfully imported 200 microdosing kits into Canada from the Netherlands with hopes that patients will be able to try microdosing through the Special Access Program.

PDF of article

Posted on

Microdosing concert for group healing

Red Light Holland Sponsors First Of Its Kind Group Microdosing Concert In The Netherlands

On Saturday, Red Light Holland (TRIP) sponsored a first-of-its-kind microdosing concert to determine best practices for group microdosing services.

Participants attended a preparation session and received a customized dose of psilocybin from a therapist.

They spent the next three hours laying on the ground listening to a live classical music concert before attending an optional integration session.

“Both music and community have healing and connective qualities and we are excited to test the potential benefits of combining microdosing psilocybin truffles in this ground-breaking setting,” says one of the event organizers

Data from the event will be used to guide microdosing regulations Oregon and Washington.

PDF of article

Posted on

Red Light Holland Appoints New Chief Marketing Officer

Red Light Holland Appoints New Chief Marketing Officer

Ridley Doolittle has been appointed as Chief Marketing Officer of Red Light Holland

Toronto, Ontario–(Newsfile Corp. – April 7, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles, is pleased to announce Ridley Doolittle will become Red Light Holland’s Chief Marketing Officer (“CMO”) effective immediately. Mr. Doolittle, formerly a Senior Brand Innovation Officer at Bacardi, previously joined Red Light Holland’s strong team of advisors, including the Chairman of the Advisory Board Bruce Linton, back in September 2021. Ridley brings a proven track record in driving accelerated growth for industry-leading brands. His extensive experience in growing consumer loved brands will further advance Red Light Holland’s growth strategy and expand Red Light Holland’s presence across our key focus markets.

“As Red Light Holland continues to grow their psychedelic products and brands in the Netherlands and other consumer packaged goods such as Happy Caps Mushroom Home Grow Kits in North America, a full time Chief Marketing Officer was a natural progression,” said Bruce Linton, Red Light Holland’s Chair of the Advisory Board. “CEO Todd Shapiro is one of the best brand strategists and marketers I’ve ever worked with but time management is key for him as Red Light Holland continues to rapidly grow. We are excited for Ridley Doolittle to join us in a full-time senior position.”

“I’m honored to have the opportunity to join the team at Red Light Holland in a larger capacity, and contribute to what I believe is an industry leading approach to the business,” added Ridley Doolittle, incoming Red Light Holland CMO. “Continuing to drive strong profitable brand growth across all of our business units will be a core focus for everything we do and I look forward to bringing my expertise to the Management team and working closely with all of them including CEO Todd Shapiro.”

“This is another significant day for Red Light Holland and all of our shareholders,” said Todd Shapiro, CEO and Director of Red Light Holland. “Ridley Doolittle will immediately help us with several important marketing initiatives focused at increasing sales while growing exposure for our unique brands. I’m really looking forward to working even closer with Ridley, who is completely aligned with Red Light Holland’s Rec and Tech approach, products, brands, mission and vision of equitable and affordable access with the goal of creating positive experiences.”

About Red Light Holland

The Company is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: https://redlight.co

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or their respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such information include statements with respect to: the appointment of Ridley Doolittle as it relates to the expected growth initiatives including increasing revenue growth and potential future marketing campaigns.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, expectations regarding future growth and expansion of the operations of the business; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets; risks related to infectious diseases, including the impacts of the COVID-19 pandemic; legal and regulatory risks inherent in the psychedelics industry, including the global regulatory landscape and enforcement related to psychedelics; political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the psychedelics industry; and such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com, including the Company’s annual information form for the year ended March 31, 2020.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Posted on

Red Light Holland CTIO, Sarah Hashkes, Publishes Microdosing Article and will be Participating in an Online Webinar by Harvard’s Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center at Harvard Law School

Red Light Holland CTIO, Sarah Hashkes, Publishes Microdosing Article and will be Participating in an Online Webinar by Harvard’s Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center at Harvard Law School

  • Red Light Holland’s Sarah Hashkes’ article titled “A Precise Definition of Microdosing Psychedelics is Needed to Promote Equitable Regulation” is currently available on the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School’s online platform
  • Hashkes to participate in an Online Webinar, A Macro View of Microdosing, with Industry Leaders on April 13th, 2022 organized by Harvard’s Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School aiming to advance evidence-based psychedelics law and policy

Toronto, Ontario–(Newsfile Corp. – April 6, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles, is pleased to announce Sarah Hashkes, the company’s Chief Technology and Innovation Officer (CTIO) will be participating in Harvard Law School’s online webinar and symposium titled ‘A Macro View of Microdosing’. The online webinar scheduled for April 13, 2022, 12:30 PM EDT will gather experts on the science, law, and business of microdosing for a panel discussion accompanied by a digital symposium on the Bill of Health, Harvard’s online platform for readers interested in news, commentary, and scholarship in the fields of health law policy, biotechnology, and bioethics. After a keynote address by Dr. James Fadiman, a longtime microdosing scholar and advocate, the event will turn to a panel discussion of the promise, risks, and future of microdosing psychedelics.

“This is a great initiative I’m proud to be part of,” said Sarah Hashkes, CTIO of Red Light Holland. “I’m excited to be able to share my expertise on the intersection of psychedelic science, commerce, and regulations with these expert thought leaders. I hope to share some of the anonymized information our users of Red Light Holland’s iMicroapp consented to share as well as our market research data from Oregon and a review of the latest scientific publications around microdosing – all in hopes of promoting responsible legal access to naturally occurring Psilocybin.”

“Red Light Holland is extremely grateful for all of Sarah Hashkes’ hard work. Our iMicro App which collects consensual data, including usage, dosage and biometric movement data of end consumers of Red Light Holland’s products in The Netherlands is essential to learn about people’s actual experiences with microdosing. It’s great that Sarah will get to share our preliminary findings, unique voice and self-regulatory approach to responsible use and legalization with other respected industry leaders and an intrigued online audience,” said Todd Shapiro, CEO and Director of Red Light Holland. “We are also grateful for Harvard’s Project on Psychedelics Law and Regulation for facilitating these important discussions and promoting expert knowledge on microdosing.”

The event is organized by Harvard’s Project on Psychedelics Law and Regulation (POPLAR), a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Launched in summer 2021 with a generous grant from the Saisei Foundation, the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School aims to advance evidence-based psychedelics law and policy.

Sarah Hashkes’s article titled “A Precise Definition of Microdosing Psychedelics is Needed to Promote Equitable Regulation” can be found at this link: https://blog.petrieflom.law.harvard.edu/2022/04/05/microdosing-psychedelics-definition/

To register for the Harvard’s Project on Psychedelics Law and Regulation (POPLAR) free online webinar go to: https://events.r20.constantcontact.com/register/eventReg?oeidk=a07ej1bbcdn85bb5c3f&oseq=&c=&ch=

About Red Light Holland

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles.

For additional information on the Company

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.RedLight.co

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding Forward Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the ability of the Company to deliver products to retail shops; the safety of the Company’s products; the uses and potential benefits of the Company’s products; the Harvard Law School’s Online webinar, keynote address, and the ensuing panel discussion proceeding as scheduled; and the CTIO of the Company to be able to attend and present the webinar to promote the responsible legal access to naturally occurring Psilocybin.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; the continued growth of the Company; the Company meeting their anticipated timeline and process for growth, sales, production and commercialization; the Company’s products being safe and providing their anticipated benefits; the Harvard Law School’s Online webinar, keynote address, and the ensuing panel discussion proceeding as scheduled; and the CTIO of the Company to be able to attend and present the webinar to promote the responsible legal access to naturally occurring Psilocybin.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the potential inability of the Company to continue as a going concern; risks associated with potential governmental and/or regulatory action with respect to the Company’s operations; competition within the markets that the Company operates in; risks with respect to the safety of the Company’s products; the risk that there is no potential benefit of the Company’s products; risk that the Company will be unable to develop its products; risk that the Harvard Law School’s Online webinar, keynote address, and ensuing panel discussion will be canceled or rescheduled; and risk that the CTIO of the Company to be unable to attend and present the webinar and/or unable to promote the responsible legal access to naturally occurring Psilocybin.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Posted on

Red Light Holland: Global Comedy Star Russell Peters to Have a Psychedelic Journey with Red Light Holland’s Natural Psilocybin Truffles and Red Light Holland’s Therapist in Amsterdam

Red Light Holland: Global Comedy Star Russell Peters to Have a Psychedelic Journey with Red Light Holland’s Natural Psilocybin Truffles and Red Light Holland’s Therapist in Amsterdam

  • Red Light Holland to reschedule a live stream in late May 2022, of an intimate Russell Peters Q & A in front of a live audience, after he completes his journey, on multiple social media accounts.
  • Red Light Holland to document Russell Peters’ moments in The Netherlands, as he will be accompanied by a camera crew.

Toronto, Ontario–(Newsfile Corp. – April 4, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles, is pleased to announce Russell Peters, the company’s Chief Creative Officer (Twitter: @TheRealRussellP – 3.9M Followers, Facebook: The REAL Russell Peters – 1.4M Followers, Instagram: @RussellPeters 502k) is expected to arrive in Amsterdam to experience his first psychedelic journey, in late May, 2022. Russell will be using Red Light Holland’s premium psilocybin truffles and will be guided by Red Light Holland’s therapist and expert psychedelic guide Jeff Hamburg. Peters will be accompanied by a camera crew and will give a special intimate Q&A hosted by CEO Todd Shapiro in front of a live audience which will be live-streamed on Red Light Holland social media accounts after he completes his journey and integration session. More details about the location and exact times, anticipated to happen in late May 2022, will be released in the near future.

“As I’ve previously said – after I deal with all my trauma – I hope I still have the ability to make people laugh,” said Russell Peters, Red Light Holland’s Chief Creative Officer. “Truthfully 2021 was a tough year for many of us. Personally, I missed performing. I missed the adrenaline of a live audience on a consistent basis. Connecting with a loyal audience is what made me who I am, and its something I’ve always been grateful for. However, through the struggles of a changing world came perspective and love. In October 2021, I actually thought I was ready for this journey – but now I’m truly ready for the Red Light Holland team to help guide me through a deeper meaning to this wild life which we all have one shot at. I hope by eventually sharing my Red Light Holland facilitated journey in a livestream during a Q&A with CEO Todd Shapiro to the world, we can try to inspire and help others. Life has ups and downs. Enjoying the ups is great, but dealing with the downs are important, as is set and setting, proper guidance and timing. The time is right. Red Light Holland and I are ready.”

“Russell and I were originally supposed to be in The Netherlands in October 2021 to bring this experience to the world – but then I unfortunately got COVID-19 and I couldn’t travel,” said Todd Shapiro, CEO and Director of Red Light Holland. “Russell was willing to go ahead but asked if we could be there together so we could talk about his experience in a candid, genuine and unstructured – real – fashion, as we’ve known each other on a personal level for quite some time now. We’ve been patient and now we’ve found a window of opportunity to make whole on his journey! Let’s hope Covid or any other unforeseen events don’t bring us down, as we are genuinely looking forward to late May. We are a very progressive company and we are not afraid to highlight our mission – of providing responsible use, affordable and equitable access to psilocybin with the goal of positive change. Russell’s willingness to share his experience is a blessing. It’s rare that you get a celebrity of his stature able to open up about such an intimate moment in their life. As I used to say, ‘stay tuned’ for more details to come soon. Much love!”

“Again, I’m excited to facilitate Russell on his truffle journey. It will be fascinating to hear Russell share his experience with the world since every journey is unique,” said Jeff Hamburg, Red Light Holland Therapist and expert psychedelic facilitator. “I am confident this will be beneficial not only to Russell himself, but to others hearing and learning about the potential benefits of such an experience.”

Red Light Holland and Russell Peters will share more details, about where and when people in the Netherlands can attend the live intimate event and where individuals all around the world can view the live-stream, in the near future.

About Red Light Holland

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles.

For additional information:

Todd Shapiro
Chief Executive Officer and Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.redlight.co

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or their respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such information include statements with respect to: the Russell Peters and Todd Shapiro’s ability to get to the Netherlands, the anticipated journey facilitated by Jeff Hamburg, the intimate live event featuring Russell Peters hosted by Todd Shapiro and the live-streaming of the event; the commencement and projected date regarding the Company’s ability to ensure the live event will happen on the Company’s social media accounts, the venue for the event; statements about the future of the live session with Russell Peters and Todd Shapiro, Jeff Hamburg providing support, with respect to live journey; and expectations for other economic, business, and/or competitive factors.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, expectations regarding future growth and expansion of the operations of the business; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets; risks related to infectious diseases, including the impacts of the COVID-19 pandemic; legal and regulatory risks inherent in the psychedelics industry, including the global regulatory landscape and enforcement related to psychedelics; political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the psychedelics industry; and such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com, including the Company’s annual information form for the year ended March 31, 2020.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

info
Posted on

Red Light Holland Announces Mushroom Home Grow Kits Produced by Happy Caps Mushroom Farm Are Now Available for Purchase in 30 Retail Stores Across Canada

Red Light Holland Announces Mushroom Home Grow Kits Produced by Happy Caps Mushroom Farm Are Now Available for Purchase in 30 Retail Stores Across Canada

Toronto, Ontario–(Newsfile Corp. – March 22, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is extremely pleased to announce that their Portfolio Company, Happy Caps Mushroom Farm’s Mushroom Home Grow Kits are now available for purchase in 30 Retail Stores Across Canada.

“We are so proud of the founders, Andrew Kobayasi and Andrew Hatfield. Kobo and Hatty have worked extremely hard with their sales team to expand points of sale for Happy Caps’ products, especially their Mushroom Home Grow kits,” said Todd Shapiro, Chief Executive Officer and Director of Red Light Holland. “We’ve always said the acquisition of Happy Caps presented a brand building opportunity for Red Light Holland, as Happy Caps’ products can currently reach consumers in a plethora of markets. It’s a pleasure to know customers are now able to purchase Happy Caps Mushroom Home Grow Kits from www.happycaps.ca, www.amazon.ca, www.amazon.com – and in 30 retail stores across Canada. The entire Happy Caps team will continue to work hard to increase points of sale so you too can hopefully ‘grow with us’!”



Pictured: Happy Caps Mushroom Home Grow Kits

To view an enhanced version of this image, please visit:
https://orders.newsfilecorp.com/files/2017/117609_111816d2b4109841_001full.jpg

“We are very pleased with our direct to consumer growth at Happy Caps, as well as our growth of getting our Mushroom Home Grow kits in retail locations. We are grateful to all the stores that are now carrying our products, including; nurseries, garden centres, farmer’s markets, seed shops, green houses and modern and trendy retail stores offering more natural and healthier food selections,” said Andrew Kobayashi, CEO of Happy Caps.

“Our strategic objectives, with the Red Light Holland team are being met – to increase our points of sale and to grow our Happy Caps brand! We are super stoked and very proud, as we continue to meet our goals, with our sights on more direct to consumer purchases and in-store retail opportunities,” said Andrew Hatfield, co-founder of Happy Caps. “This started out as an idea between two good buds, and to steal a line from Red Light Holland – it really feels like we’re going from underground to mainstream! Have a look at our Instagram page too – to learn more – www.instagram.com/happycaps.hfx.”

Happy Caps Mushroom Home Grow Kits are now available for purchase at www.HappyCaps.ca, www.Amazon.ca, www.Amazon.com and currently in 30 retail stores across Canada found in the Happy Caps Store Locator section at www.happycaps.ca/apps/store-locator.

About Happy Caps Mushroom Farm

Happy Caps is an urban gourmet mushroom farm located in Halifax, Nova Scotia that specializes in quality ‘grow your own mushroom kits’ and mushroom plug spawn.

About Red Light Holland

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles.

For additional information:
Todd Shapiro
Chief Executive Officer and Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.redlight.co

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding Forward Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the ability of the Company to deliver products to retail shops; the safety of the Company’s products; the uses and potential benefits of the Company’s products; Retail stores receiving the Company’s Products; the ability for Retail shops to sell the Company’s Home Grow Kits and other Happy Caps products, the Company’s ability to continue to grow sales in both direct to consumer and retail store’s points of sale, the Company’s ability to continue to grow the Happy Caps’ Brand; and the Company’s reliance on www.amazon.ca and www.amazon.com to continue to sell the Company’s Happy Caps’ products

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company’s ability to continue as a going concern; the Company’s ability to continue to deliver its Happy Caps products and associated consumer packaged goods; continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; the continued growth of the Company; the Company meeting their anticipated timeline and process for growth, sales, production and commercialization; the Company’s products being safe and providing their anticipated benefits; 30 Retail shops (in the store locator on the Happy Cap web-site) receiving the mushroom home grow kits and ‘other’ Happy Caps products; the Company growing sales and distribution of Happy Caps consumer packaged goods imports across the Canada; and the continued ability for the Company to sell Happy Caps products on Amazon in both Canada and the USA.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the potential inability of the Company to continue as a going concern; risks associated with potential governmental and/or regulatory action with respect to the Company’s operations; competition within the markets that the Company operates in; risks with respect to the safety of the Company’s products; the risk that there is no potential benefit of the Company’s products; risk that the Company will be unable to develop its products; risk that Retail Shops and Amazon will not receive the Happy Caps’ products; risk that retail stores and Amazon will not continue to carry Happy Caps products; risk that the Company will be unable to complete production of Happy Caps’ products; risk that the Company will be unable to deliver Happy Caps consumer packaged goods across Canada and into other North American markets including to Amazon warehouses; and risk that the Mushroom Home Grow Kit and Functional Mushroom Industry in the North America, along with their legal frameworks, will not develop.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Posted on

Red Light Holland Successfully Imports Psilocybin iMicrodose Packs into St. Vincent and the Grenadines Under a First-Ever Authorized Import Approval Process by the Country’s Bureau of Standards and the Ministry of Health

Red Light Holland Successfully Imports Psilocybin iMicrodose Packs into St. Vincent and the Grenadines Under a First-Ever Authorized Import Approval Process by the Country’s Bureau of Standards and the Ministry of Health

  • Red Light Holland’s licensed subsidiary Scarlette Lillie Sciences and Innovation granted authorization for first ever psilocybin import into St. Vincent and the Grenadines
  • Red Light Holland’s iMicrodose packs to be tested in preparation for further research with the goal of prescribed medical patient use in St. Vincent and the Grenadines
  • Red Light Holland’s iMicrodose packs to be received by Caribbean Gold Standard Laboratory in St. Vincent and the Grenadines
  • Red Light Holland continues to demonstrate their strong commitment to the highest regulatory standards

Toronto, Ontario–(Newsfile Corp. – March 21, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is extremely pleased to announce that the Government of Saint Vincent and the Grenadines (“SVG”), which had granted authorization for the Company’s iMicrodose packs to be legally imported to SVG by Red Light Holland’s licensed subsidiary Scarlette Lillie Sciences and Innovation Inc. (“Scarlette Lillie”) have cleared local Customs. The iMicrodose truffles will be received by Caribbean Gold Standard Laboratory (“CGS Labs”) in St. Vincent for testing to prepare for further research and study with the goal of eventually being prescribed for medical patient use.

“This is another groundbreaking step for the Company as we try to lead the way in legal Psilocybin-based consumer packaged goods imports across the world, with the ultimate goal of affordable and equitable access to our naturally-occurring products. We are extremely grateful for our collaborative relationship with the SVG Bureau of Standards and the Ministry of Health who worked closely with CGS Labs and Scarlette Lillie to secure authorization to import our iMicrodose packs to SVG. We look forward to completing further analysis on our branded Psilocybin Truffles so they can hopefully be cleared for future medical patient use in SVG,” said Todd Shapiro, Chief Executive Officer and Director of Red Light Holland and Scarlette Lillie. “We also appreciate the SVG Government updating the erroneous reporting by some North American Publications regarding the developments of their Modern Medicinal Wellness Industry as we continue to demonstrate our strong commitment to following the highest regulatory standards.”

“We are grateful to the SVG Government for supporting psychedelic science and taking steps towards responsible therapeutic use of naturally-occurring Psilocybin,” said Sarah Hashkes, Chief Technology Innovation Officer of Red Light Holland. “We are excited to continue to deepen our research and technology to create cutting-edge products and services.”

Shipping was coordinated by C-Crest Laboratories and Shaman Pharma in Montreal, Canada. The iMicrodose packs left Red Light Holland’s cultivation facility in the Netherlands on March 15, 2022, to St. Vincent, under a first-ever authorized import approval process by the SVG Bureau of Standards and the Ministry of Health. Confirmation has been provided by CGS Labs, the package landed at Customs on Friday, March 18th and is expected to arrive at CGS Labs in the coming days.

“We are extremely excited to be able to support the emerging psychedelic industry in SVG. We look forward to our growing partnerships with psychedelic companies, such as Red Light Holland, and the related increased need for our services as an Analytical Service Provider and Third-Party Validation Laboratory for the safe export and consumption of these products. Everyone here at CGS Labs knows this is just the beginning of realizing the opportunity that exists in developing a Natural Wellness Industry in the Organization of Eastern Caribbean States with SVG leading the effort for the region,” said Matthias Piasecki, Chief Executive Officer of CGS Labs.

This import approval and the respective shipment represent another significant milestone in advancing SVG’s methodical development of its Modern Medicinal Wellness Industry and the country’s move to develop a legal and highly-regulated medical market for psilocybin and other psychoactive compounds, entheogenic plants and fungi. On Friday, March 11, 2022, the Government of SVG released an official statement on the progress made in the development of a legal framework for its Modern Medicinal Wellness Industry, a copy of which is reproduced below:

Developments in Modern Medicinal Wellness Industry in St. Vincent and the Grenadines

The Government of Saint Vincent and the Grenadines (SVG) has approved a policy space for the establishment of a National Modern Health and Wellness Industry using plant and/or fungi-based materials. As such, the Government of St. Vincent and the Grenadines (SVG) signed a Memorandum Of Understanding (MOU) in October 2020 with three companies expressing interest in the medical use of several psychoactive compounds, broadly classed as psychedelics. This MOU outlined a period for the Medicinal Wellness Feasibility Study, in which the parties would collaborate to examine “the key elements involved in building a commercially viable, science-based, … health and wellness ecosystem in SVG.” The Study parameters would avoid premature market saturation or fragmentation through careful curation of companies on the platform, to allow a thorough assessment of the true economic impact.

The companies involved were Ajori Health & Wellness Ltd., SVG Biomed Inc. (now trading as Headland Wellness Inc), and Mera Life Sciences LLC (since acquired by Red Light Holland and renamed Scarlette Lillie Sciences and Innovation Inc.). The Ministry of Industry and the Saint Vincent and the Grenadines Bureau of Standards (SVGBS) were the enabling agencies for the government, and the parties jointly agreed that other companies could only be added to the platform by unanimous consent.

The compounds covered under the study included psilocybin, ibogaine, peyote, ketamine, dimethyltryptamine, ayahuasca and sassafras. Additional, non-psychoactive compounds were also included: namely, turmeric, aloe vera, arrowroot, soursop, ginger and moringa. Permitted licensed activities included research and development, cultivation, GXP processing, prescription and administration of the compounds in licensed clinical treatment facilities.

In the time since the commencement of the MOU, the companies have worked to support the objectives of the study and have engaged in different aspects of the Medicinal Wellness Industry. Activities have included the engagement of local and international medical professionals, the evaluation and acquisition of properties to facilitate licensed activities, the recruitment of operational professionals, and the initiation of production and supply arrangements. One of the companies has been granted permission to import a listed compound produced in another jurisdiction for analytical testing in SVG. It is expected that the three pioneering licensees will soon begin the clinical phase of the study which will expand to include clinical trial support and medically supervised treatment facilities.

The government, in turn, has conducted a thorough review of existing legislation governing the production and distribution of pharmaceutical medicines, and has created a working committee to review the progress of the companies. The government is currently addressing the drafting of a legislative framework for the establishment of a full psychedelics value chain. This has included the engagement of the international legal luminary Dr. David Berry to provide contextualization of the local industry within the legal obligations created by the international treaties governing controlled substances. Subsequently, a technical review of the industry, its participants and their operational plans has been provided to the government by Professor Leonard O’Garro.

Outside of the coverage of the MOU, two other companies have been issued Scientific Research Only licences. These licences permit local research into the same list of compounds, but do not allow commercialization, distribution, or clinical applications.

All activities in St. Vincent and the Grenadines will be in full compliance with International Law where compounds are only to be used for scientific research and medical purposes through a regulatory agency with strict national laws and regulations to ensure non-diversion of these compounds to or from the illicit market.

Recognizing the significant medical and economic potential offered by the licensed production and clinical distribution of these compounds, it is expected that the completion of the MOU study period will be followed by a seamless transition into a functional Medicinal Health and Wellness Industry. In a recent statement, the Minister of Agriculture, Forestry, Fisheries, Rural Transformation, Industry, and Labour, Hon. Saboto Caesar, congratulated the three companies for their “astute work into the ongoing feasibility study and the contribution to the build out of the Medicinal Wellness Industry here in SVG.”

– Signed by Ezra D. Ledger, Executive Director, St. Vincent and the Grenadines Bureau of Standards

About Red Light Holland

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles.

For additional information:
Todd Shapiro
Chief Executive Officer and Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.redlight.co

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release

Cautionary Statement Regarding Forward Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the ability of the Company to develop its products; the safety of the Company’s products; the uses and potential benefits of the Company’s products; CGS Labs receiving the iMicrodose packs upon its anticipated timeline; the Company completing its research and receiving its intended results upon its anticipated timeline; the iMicrodose pack being approved for medical patient use in SVG; the Company leading the way in legal Psilocybin-based consumer packaged goods imports across the world; and the Natural Wellness Industry in the Organization of Eastern Caribbean States and the SVG’s Modern Medicinal Wellness Industry, along with their legal frameworks, being developed as anticipated.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company’s ability to continue as a going concern; the Company’s ability to continue to develop its products and associated consumer packaged goods; continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; the continued growth of the Company; the Company meeting their anticipated timeline and process for production and commercialization; the Company’s products being safe and providing their anticipated benefits; CGS Labs receiving the iMicrodose packs; the Company completing its research and receiving its intended results; the iMicrodose pack being approved for medical patient use in SVG; the Company leading the way in legal Psilocybin-based consumer packaged goods imports across the world; and the Natural Wellness Industry in the Organization of Eastern Caribbean States and the SVG’s Modern Medicinal Wellness Industry, along with their legal frameworks, being developed as anticipated.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the potential inability of the Company to continue as a going concern; risks associated with potential governmental and/or regulatory action with respect to the Company’s operations; competition within the markets that the Company operates in; risks with respect to the safety of the Company’s products; the risk that there is no potential benefit of the Company’s products; risk that the Company will be unable to develop its products; risk that CGS Labs will not receive the iMicrodose packs; risk that the Company will be unable to complete its research and/or receive favourable results; risk that the iMicrodose pack will not be approved for medical patient use in SVG; risk that the Company will be unable to import consumer packaged goods across the world; and risk that the Natural Wellness Industry in the Organization of Eastern Caribbean States and the SVG’s Modern Medicinal Wellness Industry, along with their legal frameworks, will not develop.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Posted on

Red Light Holland and Advocacy Group Psychedelic Medicine Alliance Washington Celebrate the Success of their Collaboration as Washington Legislature Funds Psilocybin Wellness Workgroup

Red Light Holland and Advocacy Group Psychedelic Medicine Alliance Washington Celebrate the Success of their Collaboration as Washington Legislature Funds Psilocybin Wellness Workgroup

● Washington legislators fund $200,000 USD for a Psilocybin Wellness Workgroup to research and write a report that will inform a pathway for future legislation.
● The workgroup will include a member of the Psychedelic Medicine Alliance of Washington as well as other community, health care, and regulatory representatives.

Toronto, Ontario–(Newsfile Corp. – March 11, 2022) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles, is pleased to announce its collaboration with Psychedelic Medicine Alliance Washington (“PMAW”) has made progress in its efforts to promote legal psilocybin services in Washington State.

On Thursday, the Washington State Legislature agreed to fund a Psilocybin Wellness Workgroup administered by the state Health Care Authority in conjunction with several other state agencies and stakeholders which will review regulatory models from other states and countries. It will also gather the latest science and information on best practices from both health care professionals and current practitioners. The workgroup will then report back to the Legislature, informing future lawmakers on an appropriate model for Washington State to provide safe and accessible Psilocybin treatments to state residents 21 and older.

Led by Psychedelic Medicine Alliance of Washington (PMAW) in collaboration with Red Light Holland and Red Light Holland’s lobbyist James Paribello, their lobbying efforts helped promote state legislators to begin laying the groundwork for a regulated system of adult-use psilocybin services. After receiving powerful testimony during a public hearing from a broad spectrum of health professionals, religious practitioners, veterans, as well as indigenous persons, senators on the Health Care Committee agreed to explore a regulatory model by providing $200,000 in the state budget. The full terms of the budget approved can be found here: http://leap.leg.wa.gov/leap/Budget/Detail/2022/cosH-2990.1.pdf. Page 314; Sect. 211.

“Red Light Holland continues to deliver on our commitment to be aggressive within legal frameworks to promote legalization efforts around the world – to provide access to naturally-occurring Psilocybin,” said Todd Shapiro, CEO and Director of Red Light Holland. “This is a big win not only for Washington State but for people everywhere showing that if we stand up for what we believe in we can promote policy changes and Red Light Holland is proud to help expedite the growing movement. We hope to see similar efforts come to fruition, in time, all around the world.”

“It was amazing to see the outpour of testimonies from people sharing how Psilocybin helped them,” said Sarah Hashkes, CTIO of Red Light Holland and Washington Resident who testified before the senators. “With everything that’s happening in the world this initial ‘win’ coming from Washington State legislators is a bright beacon for a hopeful future in which psilocybin services used responsibly could help heal and connect us.”

“PMAW is extremely pleased that the Washington State Legislature has listened to the overwhelming support of their constituents by fully funding this budget proviso studying psilocybin services,” said PMAW Co-Director Kody Zalewski. “We are also extremely grateful for the support that Red Light Holland and the dedicated self-advocates have provided throughout this entire process, and we look forward to future developments as the result of this collaboration.”

While the state House and Senate have agreed to this year’s final state budget, it now must go to the Governor’s desk for his final approval and signature.

About Red Light Holland

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles.

For additional information on the Company

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.RedLight.co

About Psychedelic Medicine Alliance of Washington (PMAW)

PMAW is working to decriminalize and ensure safe and equitable access to psychedelics like psilocybin, mescaline and ayahuasca, for human health and wellness in Washington State. Ensuring personal autonomy, community sovereignty, and robust harm reduction measures related to entheogenic healing are the core to PMAW’s mission. PMAW hopes to accomplish this by dismantling outdated and harmful drug war era policies that have disproportionately impacted trauma survivors, those suffering from substance use disorder, those in poverty, and especially BIPOC communities.

For more information on PMAW check out their website: https://pmaw.org/ or contact: tatiana@decriminalizenatureseattle.org
kody@decriminalizenatureseattle.org
1.206.854.6631

Forward-Looking Statements

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, certain of which are beyond the control of Red Light Holland. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. In this news release, forward looking statements include, but are not limited to: statements with respect to the expected work to be completed by the stakeholder workgroup in Washington State.

Forward-looking information is based on a number of key expectations and assumptions made by Red Light Holland, including without limitation: the COVID-19 pandemic impact on the Canadian economy and Red Light Holland’s business, the decision of Governor Islee to fund the workgroup on the terms outlined in this news release, or at all. Although the forward-looking information contained in this news release is based upon what the Company believes to be reasonable assumptions, it cannot assure investors that actual results will be consistent with such information. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the refusal of Governor Islee to fund the stakeholder workgroup on the terms outlined in this news release, or at all.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward looking information, except as required by applicable law.